Canadian Cyclist - Cycling 4 Women
Return to Canadian Cyclist homepage
Cycling 4 Women



 

November 30/14 12:00 pm - Study Suggest PED-like Improvement Even with Placebo


Posted by Editoress on 11/30/14
 

Performance-enhancing drugs can improve a runner's best time - even when they haven't taken them, according to a University of Glasgow study.

A study examining the placebo effect found that endurance runners who thought they were injecting a fictional performance-boosting drug called OxyRBX improved their race time even though they had taken only saline.

Investigators from the University of Glasgow told 15 endurance-trained club-level runners that they were being given a new performance enhancing drug called OxyRBX which was said to improve oxygen delivery to the muscles in a similar way to a hormone called recombinant human erythropoietin (r-HuEPO).

The runners, who all had personal best times over 10km of 39.3 minutes on average, self-injected the saline placebo, thinking it to be OxyRBX, over seven days, and 3km running performance was assessed.

The runners improved their race time by an average of 1.2% - a small but significant margin after taking the placebo.

Participants reported reductions in physical effort, increased potential motivation and improved recovery after running following the saline injections.

Dr Jason Gill of the University of Glasgow said: "The change in performance was of clear sporting relevance, albeit smaller than the improvement that would be produced by r-HuEPO."

"The placebo may work by reducing perception of effort and increasing potential motivation in line with a psychological expectation of performance."

The study is published online by the journal Medicine and Science in Sports and Exercise.

See the research paper abstract Here.

 


Related Photo Galleries


Return to Cycling 4 Women homepage | Return to Canadian Cyclist homepage | Back to Top
 | 
 Privacy Policy | Contact | Subscribe to RSS Feed  | Logout
 © Copyright 1998-2024 Canadian Cyclist. All rights reserved.